FORM OF SUBSCRIPTION AGREEMENTSubscription Agreement • August 7th, 2023 • Renovaro Biosciences Inc. • Pharmaceutical preparations • Delaware
This SUBSCRIPTION AGREEMENT (this “Subscription Agreement”) is made by and between Enochian BioSciences Inc., a Delaware corporation (the “Company”), and the other signatories listed on the signature pages hereto (each, a “Subscriber”, and collectively, the “Subscribers”) as of August 1, 2023.
FORM OF COMMON STOCK PURCHASE WARRANT enochian biosciences inc.Common Stock Purchase Warrant • August 7th, 2023 • Renovaro Biosciences Inc. • Pharmaceutical preparations • Delaware
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received [●] (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time after the Issue Date (the “Initial Exercise Date”) and on or prior to the close of business on the Termination Date (as defined below) but not thereafter, to subscribe for and purchase from Enochian Biosciences Inc., a Delaware corporation (the “Company”), of up to [●] shares (subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock, par value $0.0001 per share (“Common Stock”).
PROMISSORY NOTEPromissory Note • August 7th, 2023 • Renovaro Biosciences Inc. • Pharmaceutical preparations
This Amendment No. 4 to Promissory Note (this “Amendment”), dated as of July 31, 2023 (the “Effective Date”), is entered into by and between ENOCHIAN BIOSCIENCES, INC., a Delaware corporation (the “Company”), and PASECO APS (the “Holder”).
